Thursday, September 28, 2023

Neo Health joins GBMA under new membership tier

A leading Australian healthcare company, Neo Health, has joined the Generic and Biosimilar Medicines Association (GBMA) as its first ‘Affiliate Member’, marking the ongoing growth of the peak body for affordable medicines.

Reflecting the diversity of the Australian healthcare eco-system, GBMA created the entry-level membership tier for medicine and technology manufacturers, suppliers, industry associations and patient groups, with aligned values and views.

Neo Health is an Australian based company specialising in over the counter (OTC), prescription, wellness, and personal care solutions. Their aim is to provide products for all therapeutic categories, across multiple channels and global markets to help people live healthier, happier lives.

Neo Health has links across the affordable medicines sector and an Affiliate membership of the GBMA was a ‘positive and strategic’ fit, according to Managing Director, Mr Aman Madan. 

“We share GBMA’s core objectives to ensure all Australians have secure supply and timely access to high-quality, safe and affordable medicines” Mr Madan said. 

Chief Executive Officer of the GBMA, Ms Marnie Peterson, said Neo Health had joined the organisation at an important time in the medicine policy landscape1 with cost-of-living pressures and the increasing rate of chronic disease among Australians2

“The burden of chronic disease rests heavily on the health and the hip pocket of many Australians,” Ms Peterson said.” One in five Australians have two or more chronic diseases,3 and most depend on multiple medicines and services, from multiple healthcare professionals.” 

Ms Peterson said the GBMA is working closely with the Government, members, and our stakeholders, to develop and implement effective policy reforms that better protect patients against the cost-of-living increases whilst ensuring they have affordable and timely access to the medicines and healthcare services they need.

“We welcome Neo Health to our mission to do everything we can to improve the health and financial wellbeing of all Australian patients,” Ms Peterson said. 

About the GBMA 

The Generic and Biosimilar Medicines Association (GBMA) is the peak representative body of generic and biosimilar medicine suppliers in Australia. Its members ensure that all Australians are offered the highest quality generic and biosimilar medicines in the world whilst providing affordable community health outcomes that benefit all Australians.

About Neo Health (OTC) 

Neo Health (OTC) is a proudly Australian-owned company with experience in innovation and leadership spanning more than 25 years, servicing pharmaceutical companies, pharmacy chains and grocery retailers. Neo Health develops and licenses over-the-counter, prescription, and complementary medicines, medical devices, niche, and innovative products for the Australian market.

3 The 2020-21 chronic conditions data sourced from Australian Bureau of Statistics, National Health Survey 2020-21 

Grow your portfolio and market share